The Clorox Company

Fundamentals5.0
Price Action6.0
News Sentiment6.0
AI Rating
5.0

Key Drivers

  • Strong gross margins
  • Negative working capital
  • Rising leverage

AI
AI Summary

5.0

CLX has shifted from a defensive, brand-driven yield stock to a capital-structure and execution-dependent turnaround where successful ERP stabilization and flawless GOJO integration are the make-or-break factors for preserving the dividend and avoiding dilutive financing. Require 2+ quarters of margin recovery, working-capital normalization (current ratio >1) and measurable net-debt reduction before treating this as a durable yield play; otherwise prepare for dividend cuts or equity raises.

CapitalStructure
ExecutionRisk
MonitorMetrics‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

5.0

Key Financial Insights:

  • Strong gross margins
  • Negative working capital
  • Rising leverage

Clorox remains cash-profitable with durable gross margins and strong returns but faces acute short-term liquidity stress and rising leverage after equity turned negative, warranting close balance-sheet monitoring.

OperationalStrength
LiquidityRisk

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Below last-month SMA
  • Deeply oversold
  • Defined $106 support

Price is in a bearish last-month downtrend—trading about 9% below the last-month SMA near $117 at $106.15, but is deeply oversold (RSI ~20) on clear support around $106, so a reclaim of $117 or formation of higher lows would signal a relief bounce, otherwise downside momentum likely persists.

bearish
oversold
Support Level: $106.00
Resistance Level: $117.00; multi-week $126–127

Large gap down from the late‑February peak suggesting persistent downside momentum

Sentiment & News

6.0

Key News Insights:

  • International sales up
  • Guided sales decline
  • Dividend maintained

Clorox shows early international and ERP-driven progress but faces weakening fundamentals and guided organic sales declines with tight dividend coverage.

weak_guidance
international_growth

The mix of emerging-market growth and cost-efficiency moves may support medium-term resilience, but near-term share performance is likely pressured by weaker guidance and investor caution